Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2) (Internal Region) Peptide
CITED2
Reactivité: Humain, Rat, Boeuf (Vache), Chien, Souris, Porc
Hôte: Synthetic
BP, Imm
-
- Antigène Tous les produits CITED2
- CITED2 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2))
- Protein Region
- Internal Region
- Origine
- Humain, Rat, Boeuf (Vache), Chien, Souris, Porc
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunogen (Imm)
- Séquence
- PNVIDTDFID EE
- Attributs du produit
- The peptide was used in the production of ABIN369568 - Goat Anti-CITED2 (Internal) Antibody. It is currently untested in blocking applications.
-
-
- Indications d'application
- When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Stock
- -20 °C
- Stockage commentaire
- Shipped at ambient temperature, store at -20°C.
-
- Antigène
- CITED2 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2))
- Synonymes
- mrg1 Peptide, p35srj Peptide, zgc:103418 Peptide, CITED2 Peptide, cite2 Peptide, ASD8 Peptide, MRG-1 Peptide, MRG1 Peptide, P35SRJ Peptide, VSD2 Peptide, AI835299 Peptide, ER154-like Peptide, Mrg1 Peptide, Msg2 Peptide, Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2 Peptide, Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 Peptide, Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 Peptide, Cbp/p300-interacting transactivator 2 Peptide, Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2 L homeolog Peptide, cited2 Peptide, CITED2 Peptide, cite2 Peptide, Cited2 Peptide, cited2.L Peptide
-
Vous êtes ici:
